11:01 AM EST - Tekmira Pharmaceuticals Corp. : reported a third-quarter net loss of $6.0 million or $0.12 per share, compared to net income of $1.5 million or $0.06 per share in the same quarter last year. Revenue from research and development collaborations, licensing fees and milestone payments for the quarter decreased to $4.2 million from $5.7 million in the prior year period. Tekmira Pharmaceuticals Corp.
shares T.TKM are trading down 5 cents at $0.35.
